Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05704764 · ClinicalTrials.gov registry record · NA
Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances
A NA study of HIV and Substance Use, sponsored by Friends Research Institute.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT05704764: Active NA study of HIV and Substance Use, sponsored by Friends Research Institute.
NCT05704764 is a NA study of HIV and Substance Use that is active but no longer recruiting, run by Friends Research Institute. The registered enrollment target is 70 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05704764, a NA study of HIV and Substance Use, is active but no longer recruiting, sponsored by Friends Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is: \- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes? After a year spent adapting an existing intervention to be applied specifically among people living with HIV who use substances, 70 participants will be randomized to receive either treatment-as-usual or the newly adapted intervention. The intervention itself will consist of five one-on-one sessions with a trained interventionist to discuss and work through the stigmas people commonly associate with HIV and/or substance use.
Primary Outcome
Change in Berger HIV Stigma scale scores (1 to 4, with higher scores meaning more internalized stigma)
Conditions Studied
Interventions
- BEHAVIORAL Ending Self Stigma for Persons living with HIV and Use Substances
Study Locations (2)
California
- Friends Research Institute, Inc. Satellite Office - Newhall
Maryland
- University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05704764 still lists
NCT05704764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Ending Self Stigma for Persons living with HIV and Use Substances is the first listed.
NCT05704764 reports a single indexed study location in California, Maryland.
Frequently Asked Questions
What is clinical trial NCT05704764 about?
NCT05704764 is a clinical study titled "Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances". The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is: \- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes? After a year spent adapti...
What is the current status of trial NCT05704764?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-02-17. Estimated completion is 2026-06-30.
What conditions does trial NCT05704764 study?
This clinical trial studies the following conditions: HIV, Substance Use, Stigma, Social.
What interventions are being tested in trial NCT05704764?
The interventions under investigation include: Ending Self Stigma for Persons living with HIV and Use Substances (BEHAVIORAL).
Who is sponsoring clinical trial NCT05704764?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05704764 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05704764's enrollment target sits among peer trials
70 192nd of 303 higher than 111 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI